Literature DB >> 8412605

Measurement of the extraction efficiency and distribution volume for Gd-DTPA in normal and diseased canine myocardium.

C Y Tong1, F S Prato, G Wisenberg, T Y Lee, E Carroll, D Sandler, J Wills, D Drost.   

Abstract

We have previously shown that the myocardial Gd-DTPA concentration ([Gd-DTPA]t(t)) after a bolus injection of Gd-DTPA can be predicted by the Modified Kety Equation (MKE). If [Gd-DTPA]t(t) can be determined by MRI and the data fit to the MKE, then the distribution volume (lambda) of Gd-DTPA and the myocardial flow (F) times the extraction efficiency (E), i.e., the FE product, can be determined. Therefore F can only be quantified if E is known. We measured the global E in vivo in normal canine myocardium, and measured E and lambda, in vitro, locally in normal, acute ischemic (n = 5; coronary artery occlusion < 4 h), infarcted (n = 4; coronary artery occlusion, 6 days) and reperfused (n = 4; coronary artery occlusion 2 h, and reperfusion 2 h and 6 days) myocardium. Results indicate that E differs with F and with individuals and consequently, F cannot be quantified using the MKE unless the local E is also determined in vivo.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8412605     DOI: 10.1002/mrm.1910300310

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  28 in total

1.  Direct comparison of an intravascular and an extracellular contrast agent for quantification of myocardial perfusion. Cardiac MRI Group.

Authors:  M Jerosch-Herold; N Wilke; Y Wang; G R Gong; A M Mansoor; H Huang; S Gurchumelidze; A E Stillman
Journal:  Int J Card Imaging       Date:  1999-12

Review 2.  The use of Gd-DTPA as a marker of myocardial viability in reperfused acute myocardial infarction.

Authors:  R S Pereira; F S Prato; G Wisenberg; J Sykes; K J Yvorchuk
Journal:  Int J Cardiovasc Imaging       Date:  2001-10       Impact factor: 2.357

3.  Consideration of the impact of reperfusion therapy on the quantitative relationship between the Selvester QRS score and infarct size by cardiac MRI.

Authors:  Stephanie A M Knippenberg; Galen S Wagner; Joey F A Ubachs; Anton Gorgels; Erik Hedström; Håkan Arheden; Henrik Engblom
Journal:  Ann Noninvasive Electrocardiol       Date:  2010-07       Impact factor: 1.468

Review 4.  Magnetic resonance cardiac perfusion imaging-a clinical perspective.

Authors:  Peter Hunold; Thomas Schlosser; Jörg Barkhausen
Journal:  Eur Radiol       Date:  2006-05-03       Impact factor: 5.315

5.  Analysis of microvascularity after reperfused acute myocardial infarction using the maximum slope method of contrast-enhanced magnetic resonance imaging.

Authors:  Michinobu Nagao; Hiroshi Higashino; Hiroshi Matsuoka; Hideo Kawakami; Teruhito Mochizuki; Masahiko Uemura; Nobuko Tokunaga; Kenya Murase
Journal:  Radiat Med       Date:  2008-07-27

6.  Characterization of radiofrequency ablation lesions with gadolinium-enhanced cardiovascular magnetic resonance imaging.

Authors:  Timm Dickfeld; Ritsushi Kato; Menekhem Zviman; Shenghan Lai; Glenn Meininger; Albert C Lardo; Ariel Roguin; David Blumke; Ronald Berger; Hugh Calkins; Henry Halperin
Journal:  J Am Coll Cardiol       Date:  2006-01-17       Impact factor: 24.094

Review 7.  MR first pass imaging: quantitative assessment of transmural perfusion and collateral flow.

Authors:  M Jerosch-Herold; N Wilke
Journal:  Int J Card Imaging       Date:  1997-06

Review 8.  Magnetic resonance imaging and multi-detector computed tomography assessment of extracellular compartment in ischemic and non-ischemic myocardial pathologies.

Authors:  Maythem Saeed; Steven W Hetts; Robert Jablonowski; Mark W Wilson
Journal:  World J Cardiol       Date:  2014-11-26

9.  Chronic non-transmural infarction has a delayed recovery of function following revascularization.

Authors:  Martin Ugander; Peter A Cain; Per Johnsson; John Palmer; Håkan Arheden
Journal:  BMC Cardiovasc Disord       Date:  2010-01-18       Impact factor: 2.298

Review 10.  Coronary microvascular resistance: methods for its quantification in humans.

Authors:  Paul Knaapen; Paolo G Camici; Koen M Marques; Robin Nijveldt; Jeroen J Bax; Nico Westerhof; Marco J W Götte; Michael Jerosch-Herold; Heinrich R Schelbert; Adriaan A Lammertsma; Albert C van Rossum
Journal:  Basic Res Cardiol       Date:  2009-05-26       Impact factor: 17.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.